New drug combination could delay the progression of advanced prostate cancer
A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men…
Low dose of aspirin cuts recurrence risk in colorectal cancer with genetic mutation
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical…